Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study
Authors
Collin Blakely,
Anatoly UrismanMatthew Gubens,
Claire Mulvey,
Greg Allen,
Stephen Shiboski,
Julia Rotow,
Turja Chakrabarti,
D. Kerr,
Jacqueline Aredo,
Bianca Bacaltos,
Mary Gee,
Lisa Tan,
Kirk Jones,
W. Devine,
Robert Doebele,
Dara Aisner,
Tejas Patil,
Erin Schenk,
Trever Bivona,
Jonathan Riess,
Melissa Coleman,
Johannes Kratz,
David Jablons +22 authors
,
Thea Tlsty Tip Tip